Larry Ronald Helms

Array ( [id] => 1457734 [patent_doc_number] => 06391302 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Method for treating cancers which present antigen FB5 with humanized antibodies' [patent_app_type] => B1 [patent_app_number] => 09/633653 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7199 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391302.pdf [firstpage_image] =>[orig_patent_app_number] => 09633653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1108313 [patent_doc_number] => 06809185 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Multipurpose antibody derivatives' [patent_app_type] => B1 [patent_app_number] => 09/625049 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 16966 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/809/06809185.pdf [firstpage_image] =>[orig_patent_app_number] => 09625049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560818 [patent_doc_number] => 06437115 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Nucleic acids encoding KSP, a kinesin motor protein' [patent_app_type] => B1 [patent_app_number] => 09/592037 [patent_app_country] => US [patent_app_date] => 2000-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26788 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437115.pdf [firstpage_image] =>[orig_patent_app_number] => 09592037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247514 [patent_doc_number] => 06673342 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Recombinant human IgA-J chain dimer' [patent_app_type] => B1 [patent_app_number] => 09/573440 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16587 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673342.pdf [firstpage_image] =>[orig_patent_app_number] => 09573440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758498 [patent_doc_number] => 07015312 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof' [patent_app_type] => utility [patent_app_number] => 09/571313 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 13632 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015312.pdf [firstpage_image] =>[orig_patent_app_number] => 09571313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391411 [patent_doc_number] => 06541212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-01 [patent_title] => 'Methods for detecting prostate stem cell antigen protein' [patent_app_type] => B2 [patent_app_number] => 09/564329 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 90 [patent_no_of_words] => 49372 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541212.pdf [firstpage_image] =>[orig_patent_app_number] => 09564329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1597007 [patent_doc_number] => 06492497 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Specific binding members for TGFbeta1' [patent_app_type] => B1 [patent_app_number] => 09/560198 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 16928 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492497.pdf [firstpage_image] =>[orig_patent_app_number] => 09560198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253789 [patent_doc_number] => 06670453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Multivalent antigen-binding proteins' [patent_app_type] => B2 [patent_app_number] => 09/530139 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 20920 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670453.pdf [firstpage_image] =>[orig_patent_app_number] => 09530139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419620 [patent_doc_number] => 06518402 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Antibodies to c5 polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/547983 [patent_app_country] => US [patent_app_date] => 2000-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 45564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518402.pdf [firstpage_image] =>[orig_patent_app_number] => 09547983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548566 [patent_doc_number] => 06346249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products' [patent_app_type] => B1 [patent_app_number] => 09/543004 [patent_app_country] => US [patent_app_date] => 2000-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 18410 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346249.pdf [firstpage_image] =>[orig_patent_app_number] => 09543004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280255 [patent_doc_number] => 06641999 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Probing method for identifying antibodies specific for selected antigens' [patent_app_type] => B1 [patent_app_number] => 09/503653 [patent_app_country] => US [patent_app_date] => 2000-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 77 [patent_no_of_words] => 42998 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 407 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641999.pdf [firstpage_image] =>[orig_patent_app_number] => 09503653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463205 [patent_doc_number] => 06350860 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders' [patent_app_type] => B1 [patent_app_number] => 09/485737 [patent_app_country] => US [patent_app_date] => 2000-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 44 [patent_no_of_words] => 35890 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350860.pdf [firstpage_image] =>[orig_patent_app_number] => 09485737 [rel_patent_id] =>[rel_patent_doc_number] =>)